Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 38: 873-879, 1992;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kenten, J. H.
Right arrow Articles by Massey, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kenten, J. H.
Right arrow Articles by Massey, R. J.

Clinical Chemistry, Vol 38, 873-879, Copyright © 1992 by American Association for Clinical Chemistry

Improved electrochemiluminescent label for DNA probe assays: rapid quantitative assays of HIV-1 polymerase chain reaction products

JH Kenten, S Gudibande, J Link, JJ Willey, B Curfman, EO Major and RJ Massey
IGEN Inc., Rockville, MD 20852.

We describe the characterization and utility of a new electrochemiluminescent (ECL) label for oligonucleotides, utilizing phosphoramidite chemistry. This phosphoramidite of the tris(2,2- bipyridine)ruthenium(II) complex, bis(2,2-bipyridine)(4-[4-(2- cyanoethoxy-N,N-diisopropyl-amino) phosphinoxybutyl]4'-methyl)2,2- bipyridine ruthenium(II) dihexafluorophosphate or Origen phosphoramidite, enables the direct incorporation of the label during automated DNA synthesis. Efficiency of this automated synthesis allows the direct utilization of probes without further purification. Introduction of this labeling group is reproducible, and the ECL signal recovered is not influenced by hybridization. Furthermore, neither hybridization kinetics nor hybrid stability was affected by our label. We also demonstrate the utility of these labels for the development of rapid assays with oligonucleotides direct from automated synthesis. The clinical utility of these labeled oligonucleotides is shown with assays of total nucleic acid, extracted from peripheral blood lymphocytes of patients with acquired immunodeficiency syndrome (AIDS), to detect the human immunodeficiency virus (HIV-1). The results demonstrate the ability of the assay to quantify 30-2000 copies of HIV1 gag genes and to rapidly detect (less than 45 min) HIV-1 gag genes in a nonseparation assay. The application of this assay to clinical samples demonstrates the utility of these assays for rapid and quantitative analysis.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
Z. Wang, J. Hu, Y. Jin, X. Yao, and J. Li
In Situ Amplified Chemiluminescent Detection of DNA and Immunoassay of IgG Using Special-Shaped Gold Nanoparticles as Label
Clin. Chem., October 1, 2006; 52(10): 1958 - 1961.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. Loens, T. Beck, H. Goossens, D. Ursi, M. Overdijk, P. Sillekens, and M. Ieven
Development of Conventional and Real-Time Nucleic Acid Sequence-Based Amplification Assays for Detection of Chlamydophila pneumoniae in Respiratory Specimens
J. Clin. Microbiol., April 1, 2006; 44(4): 1241 - 1244.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. Loens, M. Ieven, D. Ursi, T. Beck, M. Overdijk, P. Sillekens, and H. Goossens
Detection of Mycoplasma pneumoniae by Real-Time Nucleic Acid Sequence-Based Amplification
J. Clin. Microbiol., September 1, 2003; 41(9): 4448 - 4450.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. F. Franco, E. de Jonge, P. E. P. Dekkers, J. J. Timmerman, C. A. Spek, S. J. H. van Deventer, P. van Deursen, L. van Kerkhoff, B. van Gemen, H. ten Cate, et al.
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation
Blood, July 15, 2000; 96(2): 554 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
R. Boom, C. Sol, J. Weel, Y. Gerrits, M. de Boer, and P. Wertheim-van Dillen
A Highly Sensitive Assay for Detection and Quantitation of Human Cytomegalovirus DNA in Serum and Plasma by PCR and Electrochemiluminescence
J. Clin. Microbiol., May 1, 1999; 37(5): 1489 - 1497.
[Abstract] [Full Text]


Home page
CVIHome page
P. L. Goldschmidt, A. Devillechabrolle, Z. Ait-Arkoub, and J.-T. Aubin
Comparison of an Amplified Enzyme-Linked Immunosorbent Assay with Procedures Based on Molecular Biology for Assessing Human Immunodeficiency Virus Type 1 Viral Load
Clin. Vaccine Immunol., July 1, 1998; 5(4): 513 - 518.
[Abstract] [Full Text]


Home page
Genome ResHome page
B van Gemen, P v d Wiel, R van Beuningen, P Sillekens, S Jurriaans, C Dries, R Schoones, and T Kievits
The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application.
Genome Res., February 1, 1995; 4(4): S177 - S184.
[PDF]


Home page
Genome ResHome page
J G Lazar
Advanced methods in PCR product detection.
Genome Res., August 1, 1994; 4(1): S1 - S14.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Association for Clinical Chemistry.